PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-2.7%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.09B
AUM Growth
+$2.09B
(-16%)
Cap. Flow
-$281M
Cap. Flow
% of AUM
-13.46%
Top 10 Holdings %
Top 10 Hldgs %
34.86%
Holding
87
New
5
Increased
22
Reduced
20
Closed
15
Top Buys
| 1 |
Lantheus
LNTH
|
$25.9M |
| 2 |
Veeva Systems
VEEV
|
$16.6M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
$13.8M |
| 4 |
Day One Biopharmaceuticals
DAWN
|
$13.2M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$13.1M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$112M |
| 2 |
Penumbra
PEN
|
$40.5M |
| 3 |
Dynavax Technologies
DVAX
|
$34.9M |
| 4 |
Stryker
SYK
|
$33.6M |
| 5 |
Waters Corp
WAT
|
$25.2M |
Sector Composition
| 1 | Healthcare | 97.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tenet Healthcare
THC
$16.5B
| $38.1M | 1.8% |
578,704
+67,310
| +13% | +$4.44M |
|
27
Axsome Therapeutics
AXSM
$6.09B
| $36.6M | 1.72% |
523,210
+27,628
| +6% | +$1.93M |
|
28
Alkermes
ALKS
$4.95B
| $32.5M | 1.53% |
1,162,030
+10,646
| +0.9% | +$298K |
|
29
Caribou Biosciences
CRBU
$176M
| $32.1M | 1.51% |
6,724,715
+1,153,846
| +21% | +$5.52M |
|
30
Thermo Fisher Scientific
TMO
$183B
| $31.5M | 1.48% |
62,143
| – | – |
|
31
Sarepta Therapeutics
SRPT
$1.98B
| $30.4M | 1.43% |
250,967
+85,202
| +51% | +$10.3M |
|
32
DexCom
DXCM
$30.9B
| $29.7M | 1.4% |
318,769
-55,709
| -15% | -$5.2M |
|
33
HCA Healthcare
HCA
$95.4B
| $29.4M | 1.39% |
119,535
-39,237
| -25% | -$9.65M |
|
|
34
Day One Biopharmaceuticals
DAWN
$766M
| $27.3M | 1.29% |
2,224,598
+1,077,458
| +94% | +$13.2M |
|
35
Acadia Healthcare
ACHC
$2.15B
| $26.6M | 1.25% |
377,869
-3,433
| -0.9% | -$241K |
|
|
36
Lantheus
LNTH
$3.75B
| $25.9M | 1.22% |
+372,761
| New | +$25.9M |
|
37
Arcus Biosciences
RCUS
$1.24B
| $25.2M | 1.19% |
1,405,056
| – | – |
|
|
38
Veeva Systems
VEEV
$44.4B
| $24.2M | 1.14% |
118,905
+81,484
| +218% | +$16.6M |
|
|
KRTX
39
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $23.4M | 1.1% |
138,209
| – | – |
|
|
BLUE
40
DELISTED
bluebird bio
BLUE
| $18.4M | 0.87% |
6,040,934
-1,244,187
| -17% | -$3.78M |
|
41
Immunovant
IMVT
$2.91B
| $18.1M | 0.85% |
472,540
+83,622
| +22% | +$3.21M |
|
42
Praxis Precision Medicines
PRAX
$980M
| $15.3M | 0.72% |
8,919,997
+28,235
| +0.3% | +$48.3K |
|
43
Roivant Sciences
ROIV
$8.6B
| $14.2M | 0.67% |
1,215,033
+830,042
| +216% | +$9.69M |
|
|
IMGN
44
DELISTED
Immunogen Inc
IMGN
| $13.8M | 0.65% |
+869,889
| New | +$13.8M |
|
45
ESSA Pharma
EPIX
$11.2M
| $13M | 0.61% |
4,199,253
-5,700
| -0.1% | -$17.6K |
|
46
Universal Health Services
UHS
$11.6B
| $11.4M | 0.54% |
90,509
-192,748
| -68% | -$24.2M |
|
47
Akero Therapeutics
AKRO
$3.65B
| $10.8M | 0.51% |
+214,298
| New | +$10.8M |
|
|
PNT
48
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $10.8M | 0.51% |
1,613,516
+314,025
| +24% | +$2.09M |
|
49
Elevance Health
ELV
$72.4B
| $10.7M | 0.5% |
24,531
-50,591
| -67% | -$22M |
|
50
Generation Bio
GBIO
$40.3M
| $9.53M | 0.45% |
2,514,443
-82,993
| -3% | -$315K |
|